CP-320626 - CAS 186430-23-9
Catalog number:
186430-23-9
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C23H23ClFN3O3
Molecular Weight:
443.90
COA:
Inquire
Targets:
Glucagon Receptor
Description:
CP-320626, a carboxamide derivative, is a potent glycogen phosphorylase inhibitor and a possible target for type 2 diabetes therapy. CP-320626 is also a potent inhibitor of human muscle GPa.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Appearance:
Solid powder
Synonyms:
5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide; CP 320626; CP-320626
MSDS:
Inquire
InChIKey:
YDCGVASFVACWKF-NRFANRHFSA-N
InChI:
1S/C23H23ClFN3O3/c24-16-3-6-19-15(12-16)13-20(26-19)22(30)27-21(11-14-1-4-17(25)5-2-14)23(31)28-9-7-18(29)8-10-28/h1-6,12-13,18,21,26,29H,7-11H2,(H,27,30)/t21-/m0/s1
Canonical SMILES:
C1CN(CCC1O)C(=O)C(CC2=CC=C(C=C2)F)NC(=O)C3=CC4=C(N3)C=CC(=C4)Cl
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Glucagon Receptor Products


Adomeglivant
(CAS: 1488363-78-5)

Adomeglivant has been found to be a glucagon receptor antagonist that could probably be effective for both type-I and type-II diabetes mellitus.

Ingliforib
(CAS: 186392-65-4)

Ingliforib, with antihyperglycemic and cardioprotective properties, inhibits glycogen phosphorylase.

glucagon receptor antagonists-4
(CAS: 1393124-08-7)

glucagon receptor antagonists-4 is a potent glucagon receptor antagonist with great oral bioavailability in vivo.

CAS 202917-17-7 glucagon receptor antagonists-3

glucagon receptor antagonists-3
(CAS: 202917-17-7)

glucagon receptor antagonists-3 is a highly potent antagonist of glucagon receptor .

CAS 202917-18-8 glucagon receptor antagonists-2

glucagon receptor antagonists-2
(CAS: 202917-18-8)

glucagon receptor antagonists-2 is a highly potent antagonist of glucagon receptor .

CAS 870823-12-4 MK 0893

MK 0893
(CAS: 870823-12-4)

MK-0893 is a potent, selective glucagon receptor antagonist with high binding affinity with IC(50) of 6.6 nM and functional cAMP activity with IC(50) of 15.7 nM...

MK-0893
(CAS: 870823-19-1)

MK-0893 is a selective glucagon receptor antagonist. It can block glucagon binding to the human GCGR and antagonize glucagon-induced intracellular accumulation ...

CAS 204656-20-2 Liraglutide

Liraglutide
(CAS: 204656-20-2)

Liraglutide is the long-acting analogue of glucagon-like peptide-1 (GLP-1) receptor which could protect b-cells from apoptosis under conditions associated with ...

CAS 503559-84-0 Glucagon receptor antagonists 1

Glucagon receptor antagonists 1
(CAS: 503559-84-0)

Glucagon receptor antagonists-1 is a highly potent glucagon receptor antagonist, which is activated by glucagon and is a member of the class B G-protein coupled...

CAS 275371-94-3 Taspoglutide

Taspoglutide
(CAS: 275371-94-3)

Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist (EC50= 0.06 nM) under investigation for treatment of type 2 diabetes.

CP-320626
(CAS: 186430-23-9)

CP-320626, a carboxamide derivative, is a potent glycogen phosphorylase inhibitor and a possible target for type 2 diabetes therapy. CP-320626 is also a potent ...

Exenatide acetate
(CAS: 914454-01-6)

Exenatide acetate is a potent peptide agonist of the glucagon-like peptide 1 (GLP-1) receptor with Ki value of 136 pM. It is a 39 amino acid peptide, which incr...

CAS 133514-43-9 Exendin 9-39

Exendin 9-39
(CAS: 133514-43-9)

Exendin (9-39) is a specific and competitive glucagon-like peptide-1receptor antagonist (Kd = 1.7 nM at cloned human GLP-1 receptors). Exendin (9-39) inhibits i...

BAY-27-9955
(CAS: 202855-56-9)

BAY-27-9955 is a specific glucagon receptor antagonist.

CAS 1207989-09-0 LGD-6972

LGD-6972
(CAS: 1207989-09-0)

LGD-6972 is an orally bioavailable small molecule glucagon receptor antagonist being developed as an adjunct to diet and exercise to improve glycemic control in...

CAS 307983-31-9 GRA Ex-25

GRA Ex-25
(CAS: 307983-31-9)

GRA Ex-25 is an orally active human glucagon receptor antagonist in a transgenic murine pharmacodynamic model, with IC50 of 56 and 55 nM for rat and human gluca...

Quick Inquiry

Verification code

Featured Items